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Toxicology of the Fluoroalkenes:
Review and Research Needs
by J. Wesley Clayton*
In this review ofthe published literature on the toxicology offluoroalkenes several features emerge and
research needs are evident. The fluoroalkenes vary widely in acute inhalation toxicity. Those, such as
perfluoroisobutylene, PFIB, the most highly toxic member, attacks the pulmonary epithelium of rats
eventuating in edema and death after a delay of about one day. Other fluoroalkenes, such as hexafluoro-
propylene (HFP) or chlorotrifluoroethylene (CTFE), also cause pulmonary injury but at lower concentra-
tions produce concentration dependent changes in the renal concentrating mechanism ofthe rat. Changes
in the CNS of rats and rabbits have also been reported for CTFE. CTFE, in repeated exposures, has
produced blood pressure changes in dogs, CNS effects and changes in the erythropoietic system. This
variety ofresponses indicates the need for investigation. Chronic effects have not beensufficientdy studied
for PFIB and HFP. Thus pointing up the desirability for study. Mechanisms of action research for
fluoroalkenes is an important area ofneed. While several ideas have been suggested, there are no data to
support them. The nucleophilic sensitivity of the fluoroalkenes and the potential carcinogenic effects
stemming therefrom suggests a need field for investigation. We also can readily perceive the needs for the
evaluation of effects on reproduction (including mutagenesis and teratogenesis), metabolism pulmonary
functions, cellular function and structure. Epidemiologic studies on occupationally exposed populations
are desirable in order to adequately define human health hazard from these fluorocarbons.
Introduction
Because of legitimate concern about the tox-
icologic and environmental effects of widely used
fluoroalkane propellants such as dichlorodi-
fluoromethane (fluorocarbon 12), trichloro-
fluoromethane (fluorocarbon 11) and others which
have been in commercial use for decades, other
fluorocarbons such as the fluoroalkenes, have only
been cursorily evaluated for toxic and other
hazards. It is the purpose ofthis paper to review the
relevant published literature on the toxicology of
several fluoroalkenes and to define areas ofneed for
future toxicologic research.
That fluoroalkenes are important in toxicologic
evaluation, has been pointed out by Krespan (1).
He points out that it was recognized more than 40
years ago that fluoroalkenes such as tetra-
fluoroethylene and chlorotrifluoroethylene could be
polymerized by free-radical catalysis. This de-
velopment led naturally to a preparation of several
kinds offluoropolymers formed from the variety of
fluoroalkenes which were subsequently synthe-
*Toxicology Program, University of Arizona, Tucson,
Arizona 85721.
sized. Thus, fluoroalkenes, insofar as health
hazards were concerned, were treated mainly as in-
dustrial chemicals, prepared by the manufacturer,
subjected to appropriate toxicity evaluation, and
handled with the caution considered their due.
Consequently, they rarely if ever came in contact
with the public as the fluoroalkanes have. How-
ever, isolated accidental exposures in industry
brought the toxic potential of the fluoroalkenes
dramatically to our attention. It would seem that
the industrial controls requisite to the safe manufac-
ture and handling of these chemicals precluded sig-
nificant health hazards. Accordingly, little tox-
icologic research beyond single and shortterm re-
peated inhalation exposures has been available in
the published literature.
Chemistry
Fluoroalkenes differ from their hydrocarbon
counterparts in that the area of the double bond
tends not to be rich, but deficient in electrons be-
cause of the strong electronegativity ofthe fluorine
atoms attached to adjacent carbons. Thus fluoroal-
kenes are subject to nucleophilic attack and are
prey for bases or other nucleophiles, e.g., fluoride,
December 1977 255OH or NH2. Krespan (1) shows how the fluoride
ion (F_) is related to the chemistry of the fluoroal-
kenes in the same way as the proton (H+) is related
to the alkene hydrocarbons:
H+ + C+H2 =- CHCH2CH3 = CH3C+HCH2CH3
CH3CH = CHCH3 + H+
(1)
F- +CF2=CFCF2CF3 = CF3C-FCF2CF3
CF3CF=CFCF3 + F-
(2)
In reaction (2), migration of the double bond is ac-
complished by the movement ofthe nucleophile F-
into the double-bond electrophilic center with sub-
sequent leaving of F- to proceed down the chain.
The same event for the alkene hydrocarbons is
shown in Eq. (1). In alkene hydrocarbons, the area
ofthe double bond is electron rich thus attracting an
electrophilic proton.
Where a locus of the type present in the double
bond area of the fluoroalkenes exerts a major influ-
ence on its electronic properties, it would seem
likely that biological activity would be largely influ-
enced by the area of low electron density between
adjacent carbons and the consequent susceptibility
to nucleophilic attack. According to Chambers and
Mobbs (2) and Cook and Pierce (3), susceptibility
of fluoroalkenes to nucleophilic attack is in the fol-
lowing order:
(CF3)2-C=CF2 > CF2=CFCF3> CF2=CF2
The inhalation toxicity is in the same order per-
fluoroisobutylene > hexafluoropropylene > tetra-
fluoroethylene (Table 1). However, experimental
data bearing on this potential relationship are lack-
ing, as is information on the biologic or toxicologic
mechanisms ofaction among the fluoroalkenes. For
example, Danishevskii and Kochanov (4) claim that
the high toxicity of perfluoroisobutylene (PFIB)
stems from in vivo carbonyl fluoride formation.
Against this view, however, COF2 is lower in acute
inhalation toxicity than PFIB (5), and it produces
different biologic sequelae. The picture of COF2
toxicity is that of hydrogen fluoride. The approxi-
mate lethal concentration (ALC) ofCOF, (4-hr ex-
posures in rats) is 100 ppm, which would corre-
spond to 200 ppm of HF, a concentration in the
lethal range. It is only conjecture, but the suscepti-
bility of PFIB to nucleophilic attack might consti-
tute the basis for its high toxicity.
Acute Inhalation Toxicity
Summaries of acute inhalation toxicity of several
fluoroalkenes are found in Tables 1 and 2. A wide
range of toxicity is readily apparent in Table 1, and
while it may seem that toxicity in this class is in-
versely related to the number of fluorine atoms, in-
adequate knowledge oftoxic mechanisms at present
obviates any such conclusion. It is more likely that
some biological action related to the double bond,
as postulated above, is predominantly responsible
for the high toxicity of PFIB, rather than its com-
plement of eight fluorine atoms. The toxic
mechanism however remains to be demonstrated.
Table 1. Inhalation toxicity of several fluoroalkenes.a
Acute toxicity for ratsb
No. F ALC, LC50
Structure atoms ppm ppm
CH2=CHF 1 >800,000b
CF2=CH2 2 128,000
>800,000C
CF2=CF2 4 40,000
CF3CF=CF2 6 3,000
(CF3)2C=CF2 8 0.5, 0.76d -
aData of Clayton (5).
b4-hr exposures except where noted.
C80% CH2=CHF, 20% 02; 12.5-hr exposure.
d80% CH2=CF2, 20%o 02; 19-hr exposure.
eO.S ppm exposure was 6 hr; the 0.76 ppm exposure was 4 hr.
Table 2. Inhalation toxicity of several halogenated alkenes.a
Structure
CC12=CH2
CHCI=CC12
CC12=CC12
CC12=CF2
CC1F=CF2
No. F
atoms
0
0
0
2
3
No. Cl
atoms
2
3
4
2
1
Acute toxicity for ratsb
ALC, LC50
ppm ppm
32,000
8,000
4,000
1,000
1000
aData ofClayton (5).
bAll 4-hr exposures.
Generally, fluorinated alkenes are less toxic than
chlorinated alkenes. Table 3 brings together three
homologous pairs illustrating this point. A direct
relationship between toxicity and number of
chlorine atoms is illustrated by the sequence sig-
nifying acute inhalation toxicity ofthese chlorinated
alkenes as judged by animal inhalation exposures.
In order of decreasing toxicity we have:
CC12=CCl2 > CHCI-CC12 > CH2=CC12 > CH2=CHCI
Illustrative of fluoroalkenes of relatively low tox-
icity are vinyl fluoride (VF) (CH2=CHF) and vin-
ylidene fluoride (VF2) (CH2= CF2). As indicated
Environmental Health Perspectives 256Table 3. Toxicity comparisons among some
halogenated alkenes (rats).a
Acute inhalation toxicity, ALC,
Structure ppm (by volume)b
CH2=-CHCI >250,000c
CH2='CHF >800,()A0d
CH2=CC12 32,000
128,000
CH2=CF2 >8000OOOe
CCl2=-CC12 4,000
CF2=CF2 40,000
aData of Clayton (5).
bAll 4-hr exposures except where noted.
cGuinea pigs, 8-hr exposure. d80%o CH2=CHF, 20o 02; 12.5 hr exposure. e5OJ% CH2=CF2, 20% 02; 19-hr exposure.
tion for 39 days. Figure 1 depicts the effects of the
various levels of CTFE on the rat's ability to con-
centrate its urine. Of the three variables shown,
body weight was the least sensitive to CTFE. Rats
inhaling 460 ppm showed weight depression as com-
pared to the pre-exposure values. At 340, 240, and
125 ppm, it is debatable whether or not the body
weight curves show a weight depresssion related to
CTFE exposure because food consumption was also
down slightly. Variables reflecting renal function
were the most sensitive indices of effects. All treat-
ment levels exerted an effect on the renal concentrat-
ing mechanism, and this effect varied in a dose-
related fashion.
by Table 3, high concentrations were not lethal for
rats exposed to either VF or VF2 for 12.5 and 19 hr,
respectively. In the work by Lester and Greenberg
(6) there was no organ damage reported. Limperos
(7) conducted repeated exposures with male and
female rats inhaling 100,000 ppm VF 7 hr/day, 5
days/week, for 30 exposures. There were no
fatalities; rats gained weight normally, showed no
obvious behavioral changes, or tissue damage, as
evaluated by microscopic examination.
Fluoroalkenes of moderate to slight toxicity may
be exemplified by tetrafluoroethylene (TFE), hexa-
fluoropropylene (HFP), and chlorotrifluoro-
ethylene (CTFE). These compounds are irritating to
the respiratory tract and lungs in lethal concen-
trations asjudged by animal exposures, but in addi-
tion they also can cause kidney injury (8-10). Single
exposures ofrats to varying concentrations ofCTFE
have produced evidence of kidney dysfunction.
Radford (11), as reported by Zapp (8) demonstrated
that laboratory rats ingesting a dry diet ad libitum
voluntarily limited their water intake and conse-
quently excreted a maximally concentrated urine.
Tracking the water intake, urine volume, and solute
concentration of several rats, Radford found a high
degree of uniformity in the response of individual
rats for these variables. This suggested an exquisite
response system relating to the concentrating
mechanism ofthe renal tubular cells in the rat. When
this mechanism was disturbed, water intake and
urine volume increased while solute concentration
decreased. In order to determine possible "dose"
relationships, Radford exposed groups of male rats
for 4 hr in an inhalation chamber to 125, 240, 340, or
460 ppm of chlorotrifluoroethylene (CTFE). Work
reported by Hood et al. (10) had disclosed kidney
injury in rats inhaling CTFE. In Radford's work,
half of the rats inhaling 460 ppm died within one
week after exposure. The remaining animals sur-
vived and were observed for signs ofrenal dysfunc-
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FIGURE 1. Effects of single exposure ofchlorotrifluoroethylene:
( ) 125 ppm; (A) 240 ppm; (o) 340 ppm; (0) 460 ppm. Mean
values for groups of six male rats.
Figure 2 illustrates the dose dose/concentration re-
lationships derived from the foregoing CTFE expo-,
sures and several doses administered by subcutane-
ous injections of mercuric chloride, a comparative
control. Functional impairment of the kidney can
therefore be expressed as a decline of urine solute
concentration and increased water intake with in-
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FIGURE 2. Effects of(x) HgC12 and (o) CTFE on rat kidneys.
creasing CTFE concentrations. The threshold con-
centration for this effect appears to be around 100
ppm, approximately one tenth the 4-hr, rat LC50 Of
1000 ppm (5). Hexafluoropropylene (HFP) and tet-
rafluoroethylene (TFE) provoked similar responses
in the rat kidney, but these were both less active in
this regard than CTFE. For HFP the 4-hr rat LC50
was found to be 3000 ppm, and the threshold con-
centration forimpairment ofthe rat renal concentrat-
ing function was approximately 400 ppm (Fig. 3)
about one tenth the LC50, as with CTFE. For TFE
these values were 40,000 ppm and 500 ppm respec-
tively (5). Thesefindings in rats suggests aphysiolog-
ical basis for setting workplace standards for the
fluoroalkenes, but it is clear that detailed studies, say
on isolated renal tubules and electron microscopy,
are needed to elucidate the finer aspects of the
phenomenon just described. Furthermore, other
fluoroalkenes, e.g., VF, VF2, dichlorohexa-
fluorobutene, hexafluorocyclobutene, and per-
fluoroisobutene need to be subjected to evaluation
of effects on renal function. In addition, long-term,
repeated, low level exposures are needed.
Microscopic examination oftissues from male rats
exposed to800, 900, 1000, or 1200 ppm ofCTFEfor
4 hrwas reported by Hood et al. (10). The LC50 was
calculated as 1000 ppm. Death occurred 1-11 days
after the inhalation exposure. Pathology revealed
pulmonary edema, pleural effusion and degeneration
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FIGURE 3. Effects of hexafluoropropylene on rat renal concen-
tration for 4 hr exposure.
ofthe renal tubules. Clayton conducted kidney func-
tion studies on these rats and showed that sublethal
concentrations caused increased urine volume which
reached a high point 2 to 4 days after exposure and
gradually returned to lower volumes in the 14-day
observation period following exposure. These find-
ings agree with those observed by Radford. We need
now to study this post-exposure phase in more de-
tail. It would be important to follow the anatomical
changes (light and electron microscopy) occurring at
several points along the curves plotted in Figure 2
describing renal function changes. Of particular sig-
nificance is the so-called recovery phase. Is it in fact
"recovery?" What is the significance ofthese events
for humans accidentally exposed to these fluoroal-
kenes?
Kochanov (12) exposed groups ofrats and rabbits
for 2 hr each to various concentrations of CTFE.
The LC50 forboth ratsand rabbits was determined as
5,040 ppm. The concentrations resulting in death of
all animals from the 2-hr exposure were 5544 ppm
and 7560 ppm for rabbits and rats, respectively. The
animals became first excited, apathetic, then dys-
pneic and inactive during exposure. There was also
impairment of coordination at the highest concen-
tration of approximately 10,000 ppm. Deaths oc-
curred during the first few days after exposure. His-
tology of animals that died disclosed congestion of
internal organs, changes in the brain, and necrosis of
Environmental Health Perspectives 258the kidney tubules. The authors did not report on the
histology ofanimals that survived exposure. Neither
did they describe any changes in the water intake or
volume of urine excreted. It is also notable that the
LCT50 of 10,000 ppm-hours reported by Kochanov
(12) is about 2.5 times that of4000 ppm-hours deter-
mined by Hood et al. (10). This raises the question of
sample identity. Neither of the two groups reported
on the composition oftheir samples or the contami-
nants.
Paulet and Desbrousses (13) exposed Swiss mice
and Wistar rats to hexafluoropropylene for time
periods of0.5-8 hr. The results ofthe experiments of
these authors are summarized in Table 4. The lowest
lethal concentrations for the 8-hrexposures were 400
ppm for mice and 2000 ppm for rats. Deaths
occurred during the succeeding 10 days follow-
ing exposures. At the high levels deaths occurred
within one day.
Table 4. Acute inhalation toAicity of hexafluoropropylene.a
Duration of LC50, ppm
exposure, hr Mice Rats
½ 3000 15,750
2 1200 4,000
4 750 2,800
6 680 2,350
8 600 2,400
aData of Paulet and Desbrousses (13).
Danishevskii and Kochanov (4) report studies on
rats exposed to hexafluoropropylene, tetra-
fluoroethylene and chlorotrifluoroethylene. The fol-
lowing lethal levels were reported for 2-hr expo-
sures: hexafluoropropylene, 3,240-13,365 ppm; tet-
rafluoroethylene, 25,000 ppm; chlorotri-
fluoroethylene, 7,560 ppm. Histology of rats which
died after exposure to these three fluoroalkenes
showed pulmonary congestion and edema with de-
generative changes inliverand kidney. These levels
would be expected to be lethal on the grounds of
previously described studies. Changes that might
have occurred in urine volume and water intake
were not reported.
Investigating the toxicity of tetrafluoroethylene,
Zhemerdei (14) exposed rats and rabbits for 2 hr
each to concentrations in the range of 5000 to
100,000 ppm by volume. The lowest lethal concen-
tration for the rats exposed was 25,000 ppm. The
time ofdeath of the rats was in direct proportion to
the concentration and varied from 3 hr after expo-
sure to 16 days and more. Rats exposed to 5000 ppm
showed no signs of toxicity. At higher concentra-
tions, there was inactivity, rapid respiration and
somnolence. After exposure ended, there was de-
pression, slow respiration, inactivity and occasional
tetanic convulsions elicited by external stimuli. For
rabbits, the lowest lethal concentration was 40,000
ppm. At 10,000 ppm there were no signs oftoxicity;
above 10,000 ppm, there was inactivity and a de-
crease in respiration rate. After exposure, the rab-
bits appeared apathetic, lost appetite, and the rate
ofrespiration increased. Rabbits which succumbed
experienced a convulsion before death. Pathology
of rats and rabbits disclosed congestion of organs,
especially the brain, hemorrhage of the lungs and
spleen, and degenerative changes in the kidneys.
Considering probable differences in the kind and
quantity of contaminants in the various samples,
the work reported by Danishevskii and Kochanov
(4) and Zhermerdei (14) reveals the same order of
toxicity for the several fluoroalkenes as reported
earlier.
Referring to Table I, perfluoroisobutylene
(PFIB) is byfar the mosttoxic fluoroalkene known.
Clayton (15) reported the acute inhalation of PFIB.
Table 5 summarizes the data from the exposures,
and Figure 4 discloses time/concentration relation-
ships with mortality. Rats succumbing to PFIB
showed progressively severe tachypnea and
cyanosis and died as a result of pulmonary edema
with no effects discernible in other organ systems.
From these data and similar animal experiments
with phosgene, PFIB (LCT50 = 3 ppm-hr) is about
ten times as toxic as phosgene (LCT50 = 25 to 40
ppm-hr). The acute toxic action of these two irri-
tants appears to be directed solely at the lung.
Longer-term exposures to PFIB at levels without
deleterious effects on the lung could exert other
actions-possibly on the kidney, as has been re-
ported for CTFE and HFP.
Exposures ofrats and mice to PFIB are reported
by Danishevskii and Kochanov (4). In 2-hr expo-
sures all rats succumbed to a concentration of 1.8
ppm (vol) (3.7 ppm-hr), and the maximum tolerated
concentration was 1.6 ppm. Mice tolerated a con-
centration of 0.6 ppm while 1.2 ppm (2.4 ppm-hr)
and 1.8 ppm (3.7 ppm-hr) were the minimum lethal
and absolute lethal concentrations, respectively.
Histology disclosed pulmonary hemorrhages and
edema and degenerative changes in the kidney,
viz., albuminous, granular dystrophy and plas-
molysis [sic] of the cells of tubules. Degenerative
changes, sometimes fatty, in the liver were also re-
ported. A relationship between the degree of the
histologic reaction and the level of exposure is not
delineated by these authors. This work is in agree-
ment with that already summarized with respect to
lung changes. Changes in other organs however are
not consistent.
With the exception of Kochanov's work on
CTFE (12), Russian investigations ofthe toxicity of
December 1977 259Table 5. Summary of single exposures of rats to perfluoroisobutylene.a
Time of Mortality ratio,
Nominal concn, exposure, (no. dead/no. Clinical signs Pathological
ppm (by vol.) hr exposed) changes
1.0 4.25 2/2 Dyspnea, cyanosis, gasp- Acute pulmonary
5.33 ing convulsions edema
0.5 6.00 2/2 Slight dyspnea after ex- Acute pulmonary
posure. Both died over- edema
night
0.3 6.00 0/2 None during exposure. None observed
Slight increase in respi- 9 days after
ration rate and weight exposure
loss next day. Recov-
ered thereafter
aData of Haskell Laboratory, unpublished.
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However, the histologic changes appe
somewhat; these need to be clarified.
In their studies on fluoride ion exci
inhaling fluoroalkenes, Dilley et al. (I
hexafluoropropene (30 min exposure
produced increased urine excretion z
creased fluoride excretion. The _iure
most pronounced and lasted longer wi
pared to the other fluorocarbons inve!
inhaling HFP displayed histologic ci
kidneys which were described as dil
crosis of the proximal tubules,
eosinophila, and sloughing into the
areas. The authors conclude that the
or a metabolite thereof caused the increase in urine
volumes observed. Because only one concentration
was used, it is not possible to determine the
threshold levels of these fluorocarbons. However,
the work is in agreement with those previously cited
which demonstrated renal toxicity for the fluoroal-
kenes studied.
Dilley et al. (16) also studied the effects of tetra-
fluoroethylene (TFE), trifluoroethylene, vinylidene
fluoride, vinyl fluoride, and hexafluoroethane.
Changes like those reported for HFP were ob-
served, however, the extent of these were not as
marked as those noted for HFP. It is likely that the
changes would be dose-related and that experi-
ments at additional levels would reveal this.
Repeated Inhalation Toxicity
Few studies of the effects ofrepeated animal ex-
posures to fluoroalkenes have been reported, yet
these fluorocarbons possess the greatest potential
for biological effects.
100 200 300
isobutene. Chlorotrifluoroethylene (CTFE),
Repeated Exposures
ose the same
thors report.
ared to differ After Hood et al. (10) had determined the LC50
for CTFE in rats, viz., 1000 ppm, these inves-
retion by rats tigators went on to study the effects of repeated
6) found that exposures, Phases I and II.
at 2600 ppm) In Phase I, three dogs, male and female rats,
as well as in- male guinea pigs, and male rabbits were exposed to
tic effect was 300 ppm CTFE, 4 hr per day, 5 days per week.
ith HFP com- Eighteen exposures were actually conducted. Rats
stigated. Rats showed a slight weight loss but no other signs of
hanges in the toxic action. There were changes in the renal
ation and ne- tubules. In the guinea pigs there was one death after
cytoplasmic the sixth exposure, loss ofbody weight, and normal
intraluminal histology. Rabbits showed two deaths after the fourth
fluoroalkenes and fifth exposures, loss of body weight, normal
Environmental Health Perspectives 260histology. In dogs, blood pressure and heart rate
were normal; there was mild leucopenia and
granulocytopenia during the second and third day of
each week. Mild encephalopathy was seen in two
dogs. A third dog was not sacrificed but exposed as
follows: 300 ppm, three times; 400 ppm, seven
times; 500 ppm, two times; 600 ppm, one time; 800
ppm, three times; and 1000 ppm, one time. At each
of these steps there was temporary leucopenia.
After recovery of the white cell count, the concen-
tration of CTFE was raised to the next level. An
increase in the red blood cell count was detected
during the 400 ppm exposure; plasma cholesterol
rose slightly.
Following the exposure to 1000 ppm, the dog was
subjected by Clayton, as reported by Hood (10) to
the additional stress of exercise using a treadmill,
the objective being an attempt to sirnulate a real-life
problem where accidental exposure could be as-
sociated with considerable muscular exertion by the
individual. Heart rate was the parameter chosen to
assess this potential problem. Upon exercise, the
dog became weak and was unable to complete a
standard exercise pattern that his cohorts had no
difficulty in completing. Heart rate was signifi-
cantly elevated to 200 beats/min. No changes in
cardiac rhythm were detected even though a high,
endogenous epinephrine level was probably
reached. After his exercise period, recovery to base
line heart rate was slowed.
In order to segregate the effects of the parade of
exposures which had preceded the final one at 1000
ppm, a fourth dog was exposed once, for 4 hr, to
1000 ppm. Effects on this animal were not nearly as
dramatic. No acute toxic effects were reported, and
there was a transient drop in the white cell count
from 7100 to 2200 in the day following the exposure.
Pathologic examination revealed degenerative
neural changes which were not pronounced in the
dog which had received multiple exposures than in
the dog which had been exposed once to 1000 ppm.
Short-term, repeated exposures in dogs therefore
cause transient leucopenia, an adaptive component
(?), persistent erythrocytosis, a slight rise in plasma
cholesterol, and encephalopathy without clinically
detectable neurological abnormalities.
These findings strongly indicated that long-term,
repeated exposures could ultimately damage the
adaptive competence of the dog and provoke clini-
cally observable neurological changes to accom-
pany the encephalopathy. Accordingly, in Phase II,
a long-term investigation was carried out by these
workers. Rats, rabbits, guinea pigs, and dogs were
exposed to CTFE concentrations beginning at 15
ppm (38 exposures) and raised progressively to 30
ppm (28 exposures), 50 ppm (93 exposures), 100
ppm (56 exposures), and 150 ppm (104 exposures).
The exposures lasted 6 hr each day (excepting holi-
days) and were conducted 5 days per week for 14
months. Guinea pigs and rabbits were not affected,
clinically or anatomically by the exposure regimen.
Rats developed degenerative changes in the renal
tubules which were discovered at the end of the 14
months ofexposure. It is not known from the report
ofthis work when or at what concentration ofthose
named above the kidney response occurred. From
Radford's data previously cited, one would expect
the change to occur at the beginning of the 100-150
ppm exposure series and progressively worsen for
the remainder of the 14 months.
In the group of dogs in this experiment, overt
signs of toxicity were not noticeable through the
exposures up to 150 ppm. At this level, neurological
disturbances were observed in two dogs after 27 or
64 exposures. Changes in blood pressure became
statistically significant shortly after the 100 ppm
series was begun (Fig. 5). There was some hint of
these changes near the finish ofthe 50 ppm series. It
is probable that extending the 50 ppm level beyond
the 93 exposures would have gradually increased
the departure of the blood pressure parameters
from control limits.
Hematological evidence of changes attributable
to CTFE was also picked up during the 50 ppm
series and became statistically significant at the
higher levels. These responses were consistent with
changes in hematologic measurements made during
Phase II, viz., leucopenia, erythrocytosis (RBC,
Hemoglobin, Hematocrit), granulocytopenia, and a
slight elevation in plasma cholesterol in two dogs.
Pathologic examination of the dogs revealed
muscle atrophy and degenerative changes in the
brain, spinal cord, spinal and peripheral nerves. On
the grounds of these data, the authors suggest that
20 ppm would be a safe "ceiling" concentration for
workers potentially exposed 8 hr/day. Human data
were evidently not available for entry into this
judgement. Accidental human exposure has not
been reported. Therefore the mode of toxic action
ofCTFE in humans is, at present, not known. Until
this point is delineated, those who might be exposed
to CTFE or supervise those who might, could, from
the animal data just discussed, anticipate almost
any organ system to be affected-respiratory,
nervous, renal or hematopoietic.
The Russian investigator, Kochanov has pub-
lished results of chronic animal toxicity experi-
ments on CTFE (12). In this study, seven rabbits
were exposed 4 hr daily except Sundays and holi-
days for 58 days to 500 ppm of CTFE. Three rab-
bits died during this sequence at days 16, 29, and 30.
The concentration of CTFE was lowered on ex-
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FIGURE 5. Vital signs in dog on long-term exposure to chlorotrifluoroethylene.
posure number 59 to 250 ppm with 6-hr exposures
conducted. Rabbits experienced a reduction in
motor activity and respiratory rate. Although var-
ied, the CTFE group showed a decrease in rate of
body weight gained as compared to the control
group. Alkaline phosphatase values dropped stead-
ily throughout the 81 to 130 day exposure period.
Cholinesterase activity was increased 2 to 10 times
by CTFE exposures. No significant differences in
organ to body weight ratios were noted. His-
topathologic examination revealed a widespread
congestion of liver, spleen, and kidneys.
On comparing Kochanov's results (12) with those
of Hood et al. (10), a noteworthy similarity
emerges. Hood and co-workers exposed three rab-
bits at a lower concentration (300 ppm, Phase I and
50-150 ppm, Phase II). Neither of these proved in-
jurious to the rabbits, although it is not given in
their report whether or not they included some of
the same clinical tests (alkaline phosphatase
cholinesterase) employed by Kochanov. Hood
et al. detected no depression in growth rate or
pathologic change whereas, presumably because of
the higher CTFE concentration, Kochanov did,
and cites nonspecific congestive changes in some
organs, but without a significant decline in body
weight values.
A second chronic toxicity study (12) was under-
taken by Kochanov, using rats and rabbits exposed
to 250 ppm CTFE, 6 hr/day over a period of 70 to
110 days. Only rabbits showed a decline in growth,
as was true ofthe first series Kochanov conducted.
Rat growth lagged only slightly behind that of con-
trols. Rabbits displayed an increase in heart rate
when held in an upright position and a slowed heart
rate recovery period. Hematology of the rabbits
disclosed a hypochromic anemia, reduction of the
hemoglobin concentration, and number of erythro-
cytes; he also saw leucopenia. Hood et al. did not
report hematologic changes in rabbits, but
leucopenia was observed by them in dogs.
Kochanov's rats displayed a considerable reduc-
tion in their ability to integrate subliminal impulses,
and oxygen consumption was increased.
What do these experiments of Hood et al. (10)
and Kochanov (12) mean with regard to biologic
activity and health hazards of the fluoroalkenes?
Much! CTFE, for example, emerges as a com-
pound of widespread biologic activity capable of
provoking changes in the central nervous, respira-
tory, hematopoietic, and renal systems.
Perfluoroisobutylene (PFIB), Repeated
Exposures
Clayton (5) has reported the repeated exposure
toxicity of PFIB. This was a short experiment,
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and thus the need to evaluate its toxicity. Rats were
exposed to 0.1 ppm for 4 hr/day for 10 days. None
ofthe four rats died. During the exposures the rats
were occasionally restless and developed
tachypnea. Two ofthe four rats showed moist rales
and all appeared cyanotic occasionally. Some body
weight losses occurred but not of sufficient mag-
nitude to depress the growth curve. At the end of
the 2-week exposure period, the rats were sacrificed.
No histologic changes were attributable to PFIB.
As noted above (Tables 1 and 5), PFIB is the
most toxic of the fluoroalkenes for which studies
have been published so far. Because of its high
order of acute inhalation toxicity, a safe industrial
level is a most important question. Repeated ex-
posures ofrats lasting 10 days showed that 0.1 ppm
PFIB was tolerated by rats but there was evidence
of respiratory impairment. Therefore, before a
threshold limit value (TLV) could be reasonably
established for PFIB, repeated exposures oflonger
duration must be conducted. It is probable that
under these exposure conditions, injury to organ
systems distant from the lung could be affected, if
PFIB acts as its companion chemicals, CTFE,
HFP and TFE. Functional changes, preceding
anatomic lesions, need to be described and related
to the chemical properties of the individual
fluoroalkenes.
Dichlorohexafluorobutene-2
(DCHFB) an Impurity in Halothane
Anesthetic
The introduction of the fluorinated anesthetic,
halothane (1,1,1-trifluorobromochloroethane,
F3C-CHBrCl) in the mid 1950's constituted a land-
mark in the field ofanesthesiology. While it did not
become the ideal anesthetic, it was far superior to
the anesthetics then available. It is nonflammable
and nonexplosive at anesthetic levels and as mixed
with nitrous oxide and ether. It is also reported not
to attack the metals and plastics with which it
makes contact in vapor generators (17). Metaboli-
cally, halothane displayed the desirable qualities of
rapid uptake, absorption by adipose tissues, and
rapid elimination from the body. These features
meant desirable anesthetic properties of rapid in-
doction, ease of maintenance, and rapid recovery.
Animal toxicity experiments disclosed a low order
of inhalation toxicity for halothane and a minimal
hepatotoxic action, (17).
In 1963, Cohen et al. isolated 2,3-dichloro-1,1,-
1,4,4,4-hexafluorobutene-2 (DCHFB) from halo-
thane and reported (18) that its concentration could
increase tenfold in the vapor generator, Copper
Kettle, employed to create anesthetic concen-
trations of halothane in clinical use. Conditions
promoting the increase of DCHFB in halothane
were enrichment due to the greaterevaporation rate
ofhalothane compared to DCHFB and the reaction
ofhalothane with copper and oxygen which yielded
DCHFB. Both cis and trans isomers were present.
Because of the toxicity offluoroalkenes, it then be-
came highly important to study the toxicity of
DCHFB especially because humans undergoing
the stress of surgical procedures could prove sus-
ceptible to the toxic action of DCHFB.
Bunker and Blumenfeld (19) reported cases of
human hepatic necrosis following administration of
the anesthetic halothane, CF3CHBrCl. In investi-
gations of possible contaminants in halothane,
Cohen et al. (18) observed that DCHFB was one of
several minor contaminants in commercial samples
of halothane anesthetic, then present in undiluted
halothane at a level of 100 ppm by volume or at a
concentration of 2 ppm by volume in gaseous
anesthetic mixtures employing halothane. In 1963,
Cohen et al. (18) reviewed the known toxicity ofthe
butene, showing that it was acutely toxic for a dog
in anesthetic concentrations. Delayed onset of
anesthesia was observed and this was followed by
convulsions and death in 1 hr. About the same time,
another study by Chenoweth (20) showed that
DCHFB was lethal for rats in a 4-hr exposure at
100 ppm, but that some rats survived 100 ppm ex-
posure of 1 or 2 hr duration. Response ofrats in the
lethal exposures was consistent with pulmonary ir-
ritation. Pulmonary congestion and edema were ob-
served post-mortem. Degenerative changes in the
kidney and liver were also observed. In another
study, this author also observed fatalities in rats
from severe injury to lungs, liver, and kidney on
inhaling this fluoroalkene for 4 hr at 5 ppm.
In experiments conducted by Cohen etal. in 1965
(21), 85 male rats were exposed to
CF3-CCI=CCI-CF3 in a dynamic system for 3-hr
periods. Results indicated an LD50 for this expo-
sure of 52 ppm, with 100% fatalities at 105 ppm.
Respiratory deaths occurred in 6 to 24 hr at 840
ppm, and delayed deaths in 4 to 14 days resulted
from exposures as low as 52 ppm. The latter group
lost weight, slowly becoming lethargic, and ex-
pired. The rats exposed to the higher concentra-
tions of DCHFB showed acute hemorrhagic
changes in the lungs, while the groups exposed to
105-210 ppm showed a healing interstitial
pneumonitis and central lobular necrosis of the
liver.
Studies of the effects of CF3-CCl = CCI-CF3
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anesthesia with thiopental (150-200 mg), followed
by a 3-hr inhalation of 1% halothane with added
increments of the butene. Vaporization of the
anesthetic was with 100% oxygen. Following inser-
tion of the endotracheal tube, ventilation was sup-
ported with a respirator. Electrocardiogram, arter-
ial blood pressure, and the electroencephalogram
were monitored and intermittent determinations of
pH, Po, and Pco2were made. Initially, control ani-
mals were paired with the experimental group, and
the former maintained on 1% halothane without
added DCHFB. The LD50 determined in the dog
was 200 ppm in 1% halothane for a 3-hr exposure,
decreasing to 150 ppm for a similar anesthesia re-
peated on four consecutive days.
At 100 ppm, recovery from anesthesia followed a
normal course. Clinically, at high levels of
DCHFB, the electroencephalogram revealed fre-
quent episodes of convulsions. Analysis of blood
levels of DCHFB during seizures disclosed a level
of31 ,g/100 ml ofblood. Halothane anesthesia evi-
dently protected the dogs from violent convulsions,
because the latter appeared about 15 min after anes-
thesia was ended and halothane levels in the body
dropped, while, probably, DCHFB levels remained
sufficiently high. The seizures, if not controlled by
barbiturates and diphenylhydantoin, were fatal in
6-8 hr. A DCHFB concentration of 200 ppm pro-
voked hyperirritability, not convulsions. Death in 7
to 10 days was preceded by a downhill clinical
course-appetite loss, weight loss, and lethargy.
Post-mortem examinations showed only occasional
renal tubular damage.
In an exposure system similar to that used for
dogs, Cohen found the LD50forthe rhesus monkey,
calculated by the method ofmaximum likelihood, to
be 54 ppm for a 3-hr exposure. Death occurred
within 4 to 9 days. Convulsive disorders appeared
in the two animals exposed to 350 and 400 ppm.
Pathology revealed severe pulnonary changes in all
animals. Grossly, areas ofpneumonic consolidation
were present, and microscopically the alveolar
walls were edematous with occasional areas of ne-
crosis and covered with a thick exudative layer.
Animals living past the fifth day evidenced liver
damage, the extent ofwhich appeared related to the
concentration of DCHFB. At the lowest fatal con-
centration the liver showed atrophic changes and an
increase in lipid content, while at the highest con-
centration the animal showed central lobular ne-
crosis of the liver.
Needless to say, the discovery of an impurity
which displayed high toxicity and constituted a
hazard to the lives of surgical patients was of ex-
traordinary consequence. Raventos and Lemon
(22) reviewed the manufacturer's purity standards.
In 1956, contaminant specifications called for no
more than 0.1% by weight of total volatiles and no
more than 0.05% v/v for any one impurity. In 1965
the same specifications were 0.05% v/v and 0.01%
v/v, respectively. Analyses of halothane by these
authors revealed a cis-trans composition of 1:6.
Their toxicity studies included these isomers, iso-
lated by preparative gas-liquid chromatography, as
well as the mixed isomers as appearing in regular
manufacture.
Raventos and Lemon (22) investigated in mice,
rats, rabbits, monkeys, and dogs the acute inhala-
tion toxicity of DCHFB, other fluoroalkenes, and
fluoroalkanes which have been found as trace con-
taminants in halothane as manufactured. These au-
thors confirmed the high order of toxicity of
DCHFB [4-hr LC50: rats, 16 ppm; mice, 26 ppm;
dogs, 182 ppm; monkeys (3-hr), 90 ppm]. Table 6
presents the data on acute inhalation toxicity re-
ported by Raventos and Lemon (22) for DCHFB.
On the basis of these data, the order of toxicity for
the four species studied is rats > mice > monkeys
> dogs. Compared with PFIB, DCHFB is an order
of magnitude more toxic, based on rat data.
Table 6. Species variation and relation to time of exposure for
acute inhalation toxicity ofdichlorohexafluorobutene-2.
LC.0, ppm
I hr 2 hr 3 hr 4 hr 6 hr
Species exposure exposure exposure exposure exposure
Mice 55 39 26 20
Rats 47 28 16
Dogs 725 415 182 115
Monkeys 186 139 90
aData from Raventos and Lemon (22).
In spite ofthese differences in quantitative toxic-
ity of DCHFB, the pathological changes in the
lungs were quite uniform among the various species
studied. The pulmonary reaction was evident as
dyspnea and cyanosis during or after exposure.
Histology disclosed only pulmonary congestion and
edema. Unlike the report of hepatotoxicity of
DCHFB by Cohen (21), Raventos and Lemon (22)
observed no significant liver change; renal lesions
(small thromboses in glomerular capillaries, vacuo-
lation and degenerative changes in the first part of
the proximal tubules, and increase in the number of
colloid casts) were observed in only afew rats inhal-
ing 330-550 ppm for one hour. Raventos and Lemon
also found that the trans isomer of DCHFB was
approximately three times as toxic for mice as the
cis isomer (1-hr LC50: trans, 61 ppm; cis, 179 ppm);
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significantly different from that ofcis-trans mixture
(LC50, 55 ppm).
Cohen et al. studied metabolism and uptake of
DCHFB (21). Analyses of outflow blood from the
liver of two monkeys inhaling 1500 ppm DCHFB
for 2 hr revealed a lower amount of DCHFB than
inflow blood showed. Evidence was obtained that
DCHFB was altered by the liver cells, because
DCHFB per se could not be identified with elec-
tron capture chromatography. The uptake studies
on man indicated that DCHFB passes through the
alveolar wall and apparently is metabolized by the
subjects because exhaled DCHFB concentrations
were lower than those inhaled, and DCHFB did not
build up in the vaporizer which was supplying 1%
vol/vol halothane.
Other fluoroalkene contaminants of halothane
were studied in a preliminary manner by Raventos
and Lemon (22). The 1-hr LC50 ofCF=CClBr for
mice was 250 ppm. In addition to lung damage this
compound also produced kidney changes. This is in
agreement with the kidney effects reported above
for chlorotrifluoroethylene, tetrafluoroethylene,
and hexafluoropropylene. For the trans isomer of
CF3-CH=CBr-CF3 (BHFB), the 1-hr LC50 for
mice was 5000 ppm. Lung changes, congestion, and
edema were the predominant pathological changes,
but there was some increase in the number of liver
cells staining for lipids, however, without degenera-
tive changes. Exposures to the trans isomer of the
chloro analog, CF3-CH=CCI-CF3 (CHFB) at
16,000 ppm were not lethal for mice. Convulsions
were observed at 5000 ppm and higher. The his-
tological changes were similar to those observed
with CF3-CH-CBr-CF3.
Ferstandig (23) has published a preliminary note
on the inhalation toxicity of a 50:50 mixture of
cis-trans isomers of CHFB. For rats exposed for
15 min, the LC50 ofthis mixture was 78 ppm, equiv-
alent to approximately 20 ppm for 1-hr exposure.
Unless there is a marked difference in the toxicity
of this compound for rats as compared to mice,
which were used by Raventos and Lemon (22), it
would appear that the cis isomer is many times
more toxic than the trans isomer as noted above.
This is not the case for DCHFB, for which Raven-
tos and Lemon found the trans isomer about three
times as toxic as the cis isomer. The reports of
Cohen et al. (21) and Raventos and Lemon (22) are
contradictory, in that the former reported
hepatotoxicity for DCHFB, while Raventos and
Lemon observed no such change. Also, there are
evidently significant differences in toxicity between
the cis and trans isomers of CF3-CCI=CCI-CF3
and CF3-CH=CCI-CF3. These questions need
clarification. On balance, it appears that these
fluoroalkenes have a relatively low hepatotoxic
potential and, as such, would seem not to contribute
significantly to the post-operative hepatic disease
reported above in rare cases following halothane
anesthesia.
A study reported by Clayton (15) of the acute
inhalation toxicity of a related butene,
CF3-CF=CH-CF3, showed that 200 ppm was the
approximate lethal concentration (ALC) for a 4-hr
exposure of rats. Observations indicated that the
compound acts predominantly on the central ner-
vous or respiratory systems. Rats became sedated
during exposure; after exposure, there were weight
losses, polypnea, and quivering. Death occurred in
2-3 days. Necropsy was not conducted.
On comparing the two butenes cited above, name-
ly, CF3CH=CClCF3 and CF3CH=CFCF3,
it is noted that the chlorinated compound ap-
pears to be much more toxic than the fluorinated
compound. Effects on the liver were reported in
rats for the former. There are no comparable data
on the fluorinated compound. It is notable that
single and repeated inhalation studies on CTFE by
Hood (10) did not reveal liver damage in rats, rab-
bits, guinea pigs, or dogs. Therefore the fluoroal-
kenes cannot be lumped together when considering
their toxic actions and biologic mechanisms.
Health Effects of Fluoroalkenes
Ferstandig (23) reported an accidental exposure
of two humans who were handling CHFB. It is es-
timated that the two people were exposed about I
hr to less than 10 ppm. They experienced drowsi-
ness and shortness of breath 4-6 hr after exposure.
Pulmonary fibrosis developed in 2-3 days but later
resolved. It is evident that this material should be
handled with considerable caution in this class of
fluorocarbons.
In L'Express of September 25, 1967, the tragic
events following the exposure of 14 Pechiney em-
ployees to dichlorohexafluorobutene were reported
(24). This fluoroalkene was a primary material for
the manufacture ofaherbicide. Three ofthe workers
exposed died from pulmonary edema and fibrosis
within about two weeks after the accidental expo-
sure. Oxygen, cortisone, and antibiotics were not
successful in treating these three of the fourteen
men exposed. It is not clear how the exposure oc-
curred. In the same article, Maurel refers to a fatal
exposure in 1964 when the compound was being
studied as a degreasing agent. A laboratory techni-
cian succumbed evidently from exposure in a re-
search laboratory.
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ring in the manufacture offluorocarbons, the events
are difficult to evaluate because several compounds
may be involved, and thus the sequelae of such ex-
posures are not readily assignable to any one mater-
ial. It would be expected that humans inadvertently
inhaling fluoroalkenes would suffer pulmonary im-
pairment or injury, depending on the concentration
and duration of the inhalation. Upper respiratory
irritation is likely not to occur and therefore per-
sonnel at risk would have no sensory warning to
avoid exposure.
At exposure levels sufficient to produce pulmo-
nary injury, this would dominate the clinical re-
sponse. Other organ systems might not be affected.
However at levels low enough not to cause fatal
pulmonary impairment, the possibility ofeffects on
other systems becomes an important consideration
as to human health hazards. The models illustrating
this likelihood are the long-term animal studies on
chlorotrifluoroethylene by Hood et al. (10) and
Zapp (8).
It is clear that precautionary measures should be
taken to obviate the hazards inherent in this class of
fluorocarbons.
Exposure of the general public to fluoroalkenes
does not seem to be a significant probability, be-
cause these fluorocarbons do not now occupy the
marketplace in significant qualities. Should an in-
crease in market penetration of the fluoroalkenes
eventuate, much care will have to be exerted to
avoid unwanted exposures and additional toxico-
logic studies will be required to document more
fully the biologic activity of this class offluorocar-
bons.
Research Needs
Cook and Pierce (3) have alluded to the nu-
cleophilic sensitivity of the fluoroalkenes and have
ascribed the relative toxicities of PFIB, HFP, and
TFE to this attribute. They further compared the
fluoroalkenes to highly active alkylating agents
which are also characterized by sensitivity to nu-
cleophiles, an abundance of which are present in
biologic loci. Because of this similarity, definitive
studies are needed to evaluate the possibility that
fluoroalkenes, when contacting biologic systems,
act as alkylating agents. This brings up questions
regarding potential carcinogenic, mutagenic, and
teratogenic effects of the fluoroalkenes.
Truhaut et al. (25) have taken a different ap-
proach to the toxic action of fluoroalkenes, espe-
cially DCHFB. In animal experiments, using an
intratracheal exposure with 500 ppm and 2000 ppm
DCHB, they noted a strong acidosis. They con-
clude that formation of trifluoroacetic acid could
accountfor the pulmonary damage they observed in
rats. Lacking data, this potential mechanism needs
exploration.
Danishevskii and Kochanov (4) have suggested
that the reason for the high inhalation toxicity for
perfluoroisobutylene is the formation of carbonyl
fluoride, COF2, in the lung. No experimental data
are presented to establish this possibility. In fact,
COF2 is basically HF toxicity as shown by rat ex-
posures described earlier and PFIB is considerably
more toxic than COF2. Thus the suggestion of
Danishevskii and Kochanov would appearunlikely.
Further research on the toxicity of the fluoroal-
kenes is needed in the following areas.
(1) Long-term, repeated exposures using at least
two species three levels + two controls (I compara-
tive) should be made to establish TLV, assess pro-
gressive functional and structural kidney changes,
assess carcinogenic potential, with serial sacrifice
and recovery studies.
(2) Effects on rat reproduction with three genera-
tions, two litters per generation, with studies of
kidney and liver functions at F,b,F2b, and F3b, his-
tology at F2b and F3b, two or three test levels and
appropriate controls, and reproductive indices, in-
cluding studies in which exposures are begun at
weanling F.
(3) Teratology studies of rabbit and one other
species require three test levels and one control,
and should include behavioral studies.
(4) Mutagenesis studies should be performed on
mammalian and nonmammalian systems.
(5) Metabolic studies should include studies of
lung enzymes and induction processes, alveolar
macrophage response (phagocytosis, enzyme pro-
files, viability, 02 uptake, and other measurements,
e.g., column separation), systemic distribution,
namely absorption (tagged compounds) and excre-
tion (fluoride, organic fluorocarbons), organ per-
fusion, especially kidney, effects on kidney tubules
by electron microscopy, scanning and transmission,
and blood levels.
(6) In vitro toxicology studies on human cells
should be performed.
(7) Pathology studies should include light and
electron microscopy studies.
(8) Physiology ofupper respiratory tract changes
and mechanical, ventilatory, and diffusion proper-
ties of lungs should be investigated.
(9) Effects on several mammalian species, simi-
lar to the work of Hood (10) should be performed.
(10) Epidemiologic studies ofoccupational popu-
lations are needed.
Environmental Health Perspectives 266(11) Carcinogenic studies should include inves-
tigation of cell transformation and carcinogenicity
in long-term, low-level exposures.
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